{"nct_id":"NCT00777036","title":"A Phase II Study of Dasatinib in Children and Adolescents With Newly Diagnosed Chronic Phase Chronic Myelogenous Leukemia (CML) or With Ph+ Leukemias Resistant or Intolerant to Imatinib","status":"COMPLETED","status_verified_date":"2025-08","start_date":"2009-03-20","start_date_type":"ACTUAL","primary_completion_date":"2016-09-01","primary_completion_date_type":"ACTUAL","completion_date":"2025-01-27","completion_date_type":"ACTUAL","phases":["PHASE2"],"tickers":["BMY"]}